Frank R. Oakes

Frank R. Oakes has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Stellar Biotechnologies, Inc. and Edesa Biotech, Inc. Between 18 December 2014 and 18 February 2021, the trades on record add up to 14 filings.

Every open-market trade on record is a sale: 5 sales worth €65k. The rest of the record consists of 4 share grants and 1 option exercise. In 2021 alone, the filings show no purchases and 2 sales.

On 18 February 2021 came the latest disclosure, an open-market sale for €37k in Edesa Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.